HAPLIDENE INDUCTORS

DE502015016970D1Active Publication Date: 2024-11-21KWS SAAT SE & CO KGAA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE502015016970
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2014-11-12
Filing Date
2015-11-12
Publication Date
2024-11-21
Estimated Expiration
2035-11-12

AI Technical Summary

Technical Problem

Current methods for producing haploid and double-haploid plants in crops like maize, sorghum, rye, and sunflower lack efficient and economically viable systems, and the molecular and developmental mechanisms of existing haploid induction in maize lines derived from 'Stock 6' are not fully understood, limiting the improvement or transfer of induction suitability to non-inducer genotypes.

Method used

Development of nucleic acids and vectors that can impart or enhance the property of haploid induction in plants by influencing pollen tube growth, energy metabolism, and centromere activity, either through transgenic or non-transgenic approaches, including the use of specific genes and regulatory elements such as phospholipases and RNA methyltransferases to promote haploid development.

Benefits of technology

The proposed solution enables the production of efficient haploid inducers, potentially increasing the haploid induction rate and improving existing inducer genotypes, making haploid breeding more economically viable and understood at a molecular level.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

Field of the invention

[0001] The present invention relates to the field of plant modification using molecular biological methods and marker technology, as well as genetic engineering. It relates to the provision of technical means such as nucleic acids and vectors, as well as methods and uses for the production and identification of non-transgenic and transgenic plant haploid inducers, as well as the improvement of existing plant haploid inducers. Background of the invention

[0002] In the production of hybrid plants, two inbred lines are typically crossed as parents. Their offspring, due to the well-known heterosis effect, sometimes generate a significantly higher yield than the parent lines. Inbred lines can be maintained through multiple selfing steps, but this requires several generations and is therefore extremely time-consuming. Many years ago, modern plant breeding increasingly began to produce inbred lines through haploid induction and subsequent chromosome doubling in a much shorter time. The technical prerequisite for this is a functioning haploid induction system that also promises sufficient efficiency to be commercially viable.

[0003] For corn ( Zea mays ) is, for example, a maternal in vivoAn induction system is known in which the plant to be induced is pollinated with pollen from the inducer. Up to 10% of the resulting offspring then contain only the single (haploid) set of chromosomes of the seed parent. Several such inducers are available for maize hybrid breeding today. However, these can all be traced back to the single line "Stock 6," described in Coe (1959). An example of such a known inducer is the RWS line (Röber et al., 2005). In the past, several QTL studies have been conducted on these lines to identify the inducer-relevant loci. As early as 1997, Deimling et al. identified a major QTL on chromosome 1 (bin 1.04) in maize. More detailed mapping was carried out by Barret et al. 2008 to the region between 66.96 MB and 68.11 MB on chromosome 1, by Prigge et al. 2012 to the region between 62.9 MB and 70.8 MB, and subsequently by Dong et al.2013 to the region between 68.18 Mb and 68.43 Mb, which, according to public annotation, contains three genes. All positional information refers to the reference genome of B73, version AGPv02. The functionality of the locus alone appears to have been demonstrated by Dong et al. (2014) by achieving an induction rate of 5%. However, incorrect fine mapping cannot be ruled out, as a clear delineation of the QTL is not possible due to the lack of flanking markers in the recurrent parent.

[0004] Furthermore, WO 2012 / 030893 discloses an inducer-relevant locus on chromosome 1 in maize, which, however, differs significantly from the above locus and is located closer to the telomere. There is no overlap between the genome regions considered.

[0005] Overall, the molecular and developmental mechanisms that regulate in vivoHaploid induction in maize lines originating from "Stock 6" is still largely unknown. It is conceivable, for example, that fertilization occurs, but is subsequently followed by chromosome elimination, which then gives rise to haploid offspring. Such a mechanism has been described, for example, in a system with the histone protein CenH3 by Ravi & Chan (2010). On the other hand, fertilization may also fail to occur, and the development of the haploid egg cell takes place in the triploid endosperm. Without an understanding of the underlying maternal in vivo Haploid induction suitability of an inducer genotype derived from "Stock 6" and the knowledge of the responsible genes is a targeted improvement of this maize inducer genotype or the transfer of the induction suitability to non-inducer genotypes or the targeted induction of in vivo-Haploid induction performance in maize non-inducers is virtually impossible.

[0006] Furthermore, for some crops, no efficient and thus economically viable system for producing haploid and double haploid plants is known at all, such as sorghum, rye or sunflower.

[0007] There is therefore a need to provide genetic elements, such as genes or regulatory elements, that can be used in transgenic and / or non-transgenic approaches to enable haploid development or improved efficiency in haploid development via in vivo induction. Summary of the invention

[0008] The present invention has been made against the background of the prior art described above, the object of the present invention being to provide means and methods which can be used for producing an in vivo haploid inducer and / or for producing a haploid plant.

[0009] According to the invention, the stated object is achieved by means of a nucleic acid which, after transcription or expression in a plant, is suitable for conferring the property of a haploid inducer or for increasing the induction capacity of a haploid inducer. The nucleic acid according to the invention can be used as a transgene. Alternatively, an endogenous DNA sequence in the genome of a plant or in the genome of a plant haploid inducer, which is identical to one of the nucleic acids according to the invention, can be modified such that, after transcription or expression of the endogenous DNA sequence, the property of a haploid inducer is conferred in the plant or the induction capacity of the haploid inducer is increased. The nucleic acid of the present invention is preferably an isolated nucleic acid which has been removed from its natural or original environment (genetic context).A nucleic acid can be double-stranded or single-stranded, linear or circular. It can be genomic DNA, synthetic DNA, cDNA, or a type of RNA (e.g., lncRNA, siRNA, or miRNA), whereby in RNA, the nucleobase uracil occurs instead of the nucleobase thymine.

[0010] In a preferred embodiment of the present invention, the nucleic acid according to the invention or an RNA encoded by the nucleic acid or a protein or polypeptide encoded by the nucleic acid influences the pollen tube growth in a plant, the energy metabolism of a pollen of a plant and / or the activity of the centromere, preferably in a generative cell which, for example, develops into a pollen.

[0011] The nucleic acid according to the invention can be characterized in that the nucleic acid or an RNA encoded by the nucleic acid or a protein or polypeptide encoded by the nucleic acid is suitable or can be used, for example, to accelerate or promote pollen tube growth in pollen of a plant compared to pollen of a wild-type plant in which the nucleic acid according to the invention or an RNA encoded by the nucleic acid or a protein or polypeptide encoded by the nucleic acid is not used as described below. The nucleic acid according to the invention encodes, for example, enzymes of the class of phospholipases, in particular phospholipase A2 or patatin phospholipase, capable of promoting pollen tube growth (Kim et al., 2011).The nucleic acid according to the invention can be used as a transgene for the purpose of accelerated pollen tube growth, wherein it then, for example, by means of an overexpression approach, increases the expression rate of a pollen tube growth-promoting gene or the transcription rate of an RNA such as an lncRNA, which positively regulates (activates) a pollen tube growth-promoting gene or negatively regulates (inhibits) pollen tube growth-inhibiting gene, in a plant or a part thereof compared to a wild-type plant or a corresponding part thereof and / or by means of an RNAi approach or miRNA approach (Fire et al., 1998), the expression rate of a pollen tube growth-inhibiting gene is reduced in a plant or a part thereof compared to a wild-type plant or a corresponding part thereof.On the other hand, an endogenous DNA sequence in the genome of a plant or in the genome of a plant haploid inducer that is identical to the nucleic acid of the invention, or a regulatory sequence of the endogenous DNA sequence, can also be modified, for example, by mutagenization or genome editing. This modification can increase or decrease the transcription or expression rate of the endogenous DNA sequence, or the activity or stability of the protein or polypeptide encoded by the endogenous DNA sequence in a plant compared to a non-mutagenized wild-type plant.Thus, for example, the expression rate of an endogenous pollen tube growth-promoting gene or the transcription rate of an endogenous RNA such as an lncRNA that positively regulates (activates) a pollen tube growth-promoting gene or negatively regulates (inhibits) a pollen tube growth-inhibiting gene can be increased in a plant compared to a non-mutagenized or genome-editing modified wild-type plant, or the expression rate of an endogenous pollen tube growth-inhibiting gene or the transcription rate of an RNA such as an lncRNA that negatively regulates (inhibits) a pollen tube growth-promoting gene or positively regulates (activates) a pollen tube growth-inhibiting gene can be reduced in a plant compared to a non-mutagenized or genome-editing modified wild-type plant.In addition, the activity or stability of a pollen tube growth-promoting protein or polypeptide encoded by the endogenous DNA sequence may be increased in a plant compared to a non-mutagenized or genome-edited wild-type plant, or the activity or stability of a pollen tube growth-inhibiting protein or polypeptide encoded by the endogenous DNA sequence may be reduced in a plant compared to a non-mutagenized or genome-edited wild-type plant.

[0012] In a further example, the nucleic acid according to the invention can be characterized in that the energy metabolism of pollen in a plant is impaired compared to a wild-type plant through the use of the nucleic acid or an RNA encoded by the nucleic acid or a protein or polypeptide encoded by the nucleic acid. This can be achieved, for example, by a phosphoglycerate mutase. The nucleic acid according to the invention can be used for this purpose as a transgene in an overexpression approach or in an RNAi approach or miRNA approach (Fire et al., 1998). On the other hand, an endogenous DNA sequence in the genome of a plant or in the genome of a plant haploid inducer, which is identical to the nucleic acid according to the invention, or a regulatory sequence of the endogenous DNA sequence can be modified, for example, by mutagenization or genome editing.This modification may increase or decrease the transcription or expression rate of the endogenous DNA sequence or the activity or stability of the protein or polypeptide encoded by the endogenous DNA sequence in the plant compared to a non-mutagenized or genome-edited wild-type plant.

[0013] In another example, the nucleic acid according to the invention can also be characterized in that, through the use of the nucleic acid or an RNA encoded by the nucleic acid or a protein or polypeptide encoded by the nucleic acid, the activity of the centromere in a plant, in particular in early embryogenesis and preferably in a generative cell of the plant which, for example, develops into pollen, is altered compared to a wild-type plant, which can, for example, lead to the elimination of the inducer genome. The activity of the centromere can be altered via chromatin modification at the DNA or histone level, as well as by transcription, RNA interactions, or RNA binding. A change in the activity of the centromere can occur, for example, by a methyltransferase such as an RNA methyltransferase.The nucleic acid according to the invention can be used for this purpose as a transgene, for example, by means of an overexpression approach to increase the expression rate of a chromatin-modifying gene or the transcription rate of an RNA such as an lncRNA that positively regulates (activates) a chromatin-modifying gene in a plant compared to a wild-type plant. Alternatively, an endogenous DNA sequence in the genome of a plant or in the genome of a plant haploid inducer that is identical to the nucleic acid according to the invention, or a regulatory sequence of the endogenous DNA sequence, can also be modified, for example, by mutagenization or genome editing.This modification can increase or decrease the transcription or expression rate of the endogenous DNA sequence, or the activity or stability of the protein or polypeptide encoded by the endogenous DNA sequence, in a plant compared to the non-mutagenized or genome-edited wild-type plant. Thus, the expression rate of an endogenous chromatin-modifying gene or the transcription rate of an endogenous RNA, such as an lncRNA that positively regulates (activates) a chromatin-modifying gene, can also be increased in a plant compared to the non-mutagenized or genome-edited wild-type plant. Furthermore, the activity or stability of a chromatin-modifying protein encoded by the endogenous DNA sequence can be increased in a plant compared to the non-mutagenized or genome-edited wild-type plant.

[0014] The above-described uses of the nucleic acid according to the invention or of an RNA encoded by the nucleic acid or of a protein or polypeptide encoded by the nucleic acid are not exhaustive or restrictive, but are to be understood merely as examples. A person skilled in the art is aware of numerous other technical means and methods with which he can effect the above-described changes in the expression or transcription rate of the nucleic acid according to the invention or of the identical endogenous DNA sequence, or the above-described changes in the stability and activity of the protein or polypeptide encoded by the nucleic acid according to the invention or the endogenous DNA sequence.

[0015] In a particularly preferred embodiment of the present invention, the nucleic acid which, after transcription or after expression in a plant, is suitable for imparting the property of a haploid inducer or for increasing the induction performance of a haploid inducer, can be a nucleic acid which comprises a nucleotide sequence which (i) has a sequence selected from SEQ ID NOs: 9, or (ii) is complementary to a sequence from (i), or (iii) is at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, or particularly preferably at least 97%, 97.5%, 98%, 98.5%, 99% or 99.5% identical to a sequence from (i), or (iv) for a protein having the amino acid sequence selected from SEQ ID NOs: 23.

[0016] This nucleic acid can code for a protein or a functional part thereof, wherein the protein or the functional part thereof has the functionality of a phospholipase, in particular a phospholipase A2 or a patatin phospholipase (see Table 1). The nucleic acid can be used as described above, i.e. in order to confer the property of a haploid inducer in a plant or to increase the induction performance of a haploid inducer, for example, the expression rate of the nucleic acid or the activity or stability of the encoded protein or the encoded part of the protein is to be increased transgenically or endogenously. Since this nucleic acid or an RNA encoded by the nucleic acid or a protein or polypeptide encoded by the nucleic acid has a positive effect on the haploid induction performance of a plant, a nucleic acid as defined here is referred to below as an induction-promoting nucleic acid.Further methods and uses of the induction-promoting nucleic acid as well as articles comprising the induction-promoting nucleic acid are disclosed below.

[0017] In a further particularly preferred embodiment of the present invention, the nucleic acid which, after transcription or after expression in a plant, is suitable for imparting the property of a haploid inducer or for increasing the induction performance of a haploid inducer, can be a nucleic acid which codes for an RNA which has a double-stranded part, wherein at least one strand of the double-stranded part has a nucleotide sequence which is nucleotide-free with at least 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 or 25, preferably with at least 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 120 or 140, particularly preferably with at least 160, 180, 200, 250, 300, 350, 400, 450, 500, 600, 700, 800, 900 or 1000 consecutive nucleotides of an intron sequence of a nucleic acid which (i) has a sequence selected from SEQ ID NOs: 9 or a fragment thereof in sense or antisense orientation, or (ii) is complementary to a sequence from (i), or (iii) is at least 90%, 91%, 92%, 93%, 94%, 95% or 96% identical to a sequence from (i), or particularly preferably at least 97%, 97.5%, 98%, 98.5%, 99% or 99.5% identical, or (iv) encodes a protein having the amino acid sequence selected from SEQ ID NOs: 23 or a part of the protein Table 1: Sequence index and sequence assignment of the nucleotide and amino acid sequences. The names of the gene families / protein families correspond to the public models. Structural changes in the inducers may result in different functionalities. SEQ ID NO: Gene family / protein family - identifier / / derived gene model Sequence type source 1 GRMZM2G179789 SNAREv 1 genomic DNA B73 2 GRMZM2G179789 SNAREv 1 cDNA B73 3 GRMZM2G179789 SNAREv 1 cDNA (variant 1) RWS 4 GRMZM2G179789 SNAREv 1 cDNA (variant 2) RWS 5 GRMZM2G179789 SNAREv 1 cDNA (partial sequence from nucleotide 1240 to 2321 of SEQ ID NO: 3) RWS 6 GRMZM2G412426 SNAREv 2 genomic DNA B73 7 GRMZM2G412426 SNAREv 2 cDNA B73 8 GRMZM2G471240 Patatin phospholipase genomic DNA including flanks B73 9 GRMZM2G471240 Patatin phospholipase genomic DNA including flanks RWS 10 GRMZM2G471240 Patatin phospholipase cDNA B73 11 GRMZM2G471240 Patatin phospholipase cDNA RWS 12 GRMZM2G347808 RNA methyltransferase genomic DNA including flanks B73 13 GRMZM2G347808 RNA methyltransferase genomic DNA including flanks RWS 14 GRMZM2G347808 RNA methyltransferase cDNA B73 15 GRMZM2G347808 RNA methyltransferase cDNA RWS 16 GRMZM2G179789 SNAREv 1 Polypeptide (variant 1) B73 17 GRMZM2G179789 SNAREv 1 Polypeptide (variant 2) B73 18 GRMZM2G179789 SNAREv 1 Polypeptide (variant 1) RWS 19 GRMZM2G179789 SNAREv 1 Polypeptid (Variante 2) RWS 20 GRMZM2G412426 SNAREv 2 Polypeptid B73 21 GRMZM2G471240 Patatin-Phospholipase Polypeptid (Variante 1) B73 22 GRMZM2G471240 Patatin-Phospholipase Polypeptid (Variante 2) B73 23 GRMZM2G471240 Patatin-Phospholipase Polypeptid RWS 24 GRMZM2G347808 RNA-Methyltransferase Polypeptid B73 25 GRMZM2G347808 RNA-Methyltransferase Polypeptid RWS 26 GRMZM2G106834 Phosphoinositolphosphatase genomisch DNA B73 27 GRMZM2G106834 Phosphoinositolphosphatase cDNA (Variante 1) B73 28 GRMZM2G106834 Phosphoinositolphosphatase cDNA (Variante 2) B73 29 GRMZM2G106834 Phosphoinositolphosphatase cDNA (Variante 3) B73 30 GRMZM2G062320 Phosphoglycerat-Mutase genomisch DNA B73 31 GRMZM2G062320 Phosphoglycerat-Mutase cDNA B73 32 GRMZM2G106834 Phosphoinositolphosphatase Polypeptid (Variante 1) B73 33 GRMZM2G106834 Phosphoinositolphosphatase Polypeptid (Variante 2) B73 34 GRMZM2G062320 Phosphoglycerat-Mutase Polypeptid B73 35 IncRNA zur Phosphoinositolphosphatase cDNA (Variante 1) B73 36 IncRNA zur Phosphoinositolphosphatase cDNA (Variante 2) B73 37 IncRNA zur Phosphoinositolphosphatase cDNA (Variante 3) B73 38 IncRNA zur Phosphoinositolphosphatase cDNA RWS 39 IncRNA for Phospholipase genomic DNA B73 40 IncRNA zur Phosphoinositolphosphatase Polypeptide (Variant 1) B73 41 IncRNA zur Phosphoinositolphosphatase Polypeptide (Variant 2) B73

[0018] In a further aspect, the present invention relates to a vector comprising the nucleic acid according to the invention. The vector can be a plasmid, a cosmid, a phage, or an expression vector, a transformation vector, a shuttle vector, or a cloning vector; it can be double- or single-stranded, linear or circular, or can transform a prokaryotic or eukaryotic host either by integration into its genome or extrachromosomally. Preferably, the nucleic acid according to the invention is operatively linked in a vector to one or more regulatory sequences that allow transcription and, optionally, expression in a prokaryotic or eukaryotic host cell. A regulatory sequence, preferably DNA, can be homologous or heterologous to the nucleic acid according to the invention. For example, the nucleic acid is under the control of a suitable promoter or terminator.Suitable promoters can be promoters that are constitutively induced (e.g., the 35S promoter from the "Cauliflower mosaic virus" (Odell et al. 1985). Particularly suitable are promoters that are tissue-specific (e.g., pollen-specific promoters, Chen et al. (2010), Zhao et al. (2006), or Twell et al. (1991), or development-specific (e.g., flowering-specific promoters). Suitable promoters can also be synthetic or chimeric promoters, which do not occur naturally, are composed of several elements, and contain a minimal promoter, as well as at least one cis-regulatory element upstream of the minimal promoter, which serves as a binding site for specific transcription factors. Chimeric promoters can be designed according to the desired specificities and are induced or repressed by different factors. Examples of such promoters can be found in Gurr & Rushton (2005) or Venter (2007).A suitable terminator is, for example, the nos terminator (Depicker et al., 1982).

[0019] In addition to the vectors described above, the present invention also provides a method comprising introducing a described vector into a host cell. The vector can be introduced, for example, by conjugation, mobilization, biolistic transformation, Agrobacterium-mediated transformation, transfection, transduction, vacuum infiltration, or electroporation. Such methods, as well as methods for preparing described vectors, are familiar to those skilled in the art (Sambrook et al. 2001).

[0020] In a further aspect, the present invention relates to a host cell comprising the nucleic acid according to the invention or the vector of the present invention. A host cell within the meaning of the invention can be a prokaryotic (e.g. bacterial) or eukaryotic cell (e.g. a plant cell or a yeast cell). Preferably, the host cell is an Agrobacterium such as Agrobacterium tumefaciens or Agrobacterium rhizogenesor a plant cell comprising the nucleic acid of the invention or the vector of the present invention. The skilled person is familiar with numerous methods, such as conjugation or electroporation, by which the nucleic acid of the invention or the vector of the present invention can be introduced into an Agrobacterium, as well as methods such as various transformation methods (biolistic transformation, Agrobacterium-mediated transformation) by which the nucleic acid of the invention or the vector of the present invention can be introduced into a plant cell (Sambrook et al. 2001).

[0021] In a further aspect, the present invention relates to a transgenic plant cell comprising the nucleic acid according to the invention as a transgene or the vector of the present invention, and to a transgenic plant or a part thereof comprising the transgenic plant cell. Such a transgenic plant cell or plant is, for example, a plant cell or plant that has been transformed, preferably stably, with the nucleic acid according to the invention or with the vector of the present invention. A transgenic plant of the present invention is preferably suitable for use as a haploid inducer. In a preferred embodiment of the transgenic plant, the nucleic acid is operatively linked to one or more regulatory sequences that allow transcription and optionally expression in the plant cell. A regulatory sequence, preferably DNA, can be homologous or heterologous to the nucleic acid according to the invention.The overall construct comprising the nucleic acid according to the invention and the regulatory sequence(s) can then represent the transgene. A part of a plant can be a fertilized or unfertilized seed, an embryo, pollen, a tissue, an organ, or a plant cell, wherein the fertilized or unfertilized seed, the embryo, or the pollen is produced on the transgenic plant and into whose genome the nucleic acid according to the invention is integrated as a transgene or the vector. Likewise, the present invention also includes a progeny of the transgenic plant, into whose genome the nucleic acid according to the invention is integrated as a transgene or the vector and which is suitable for use as a haploid inducer.

[0022] In another aspect, the present invention relates to a protein or polypeptide encoded by a nucleic acid according to the invention. Preferably, the protein or polypeptide is suitable for conferring the property of a haploid inducer in a plant or for increasing the induction performance of a haploid inducer. Particularly preferably, the protein or polypeptide is encoded by the induction-inducing nucleic acid. Preferably, a protein or polypeptide of the present invention comprises an amino acid sequence selected from SEQ ID NOs: 23.

[0023] In a further aspect, the present invention describes a method for producing a plant suitable for use as a haploid inducer. The method may comprise the following steps: A) mutagenizing plant cells and subsequently regenerating plants from the mutagenized plant cells or mutagenizing plants, and B) identifying a plant from A) which has at least one mutation in an endogenous DNA sequence which is identical to the nucleic acid according to the invention or in a regulatory sequence of the endogenous DNA sequence such as a promoter, enhancer, terminator or intron, which causes a change in the transcription or expression rate of the endogenous DNA sequence in the identified plant compared to a non-mutagenized wild-type plant or a change in the activity or stability of a protein or polypeptide encoded by the endogenous DNA sequence in the identified plant compared to a non-mutagenized wild-type plant, wherein the at least one mutation causesthat the property of a haploid inducer is conferred in the identified plant or the induction capacity of a haploid inducer is increased. Preferably, the change in the transcription or expression rate or the change in activity or stability is evident in at least one pollen of the identified plant or in one tissue of a pollen of the identified plant.

[0024] Preferably, the endogenous DNA sequence from step B) or an RNA encoded by the endogenous DNA sequence or a protein or polypeptide encoded by the endogenous DNA sequence influences pollen tube growth in a plant, the energy metabolism of pollen of a plant and / or the activity of the centromere, preferably in a generative cell which, for example, develops into pollen.

[0025] Particularly preferably, the endogenous DNA sequence from step B) of the process for producing a plant suitable for use as a haploid inducer encodes an enzyme of the class of phospholipases, in particular phospholipase A2 or patatin phospholipase, wherein the transcription or expression rate or the activity or stability is preferably modified such that it is increased.

[0026] A mutation means a modification at the DNA level, i.e. a change in genetics and / or epigenetics. For example, a change in genetics can be the exchange of at least one nucleobase in the endogenous DNA sequence or in a regulatory sequence of the endogenous DNA sequence. If such a nucleobase exchange occurs, for example, in a promoter, this can lead to altered activity of the promoter. This can happen because, for example, cis-regulatory elements are modified in such a way that the affinity of a transcription factor to the mutated cis-regulatory element is altered compared to the wild-type promoter. The activity of the promoter with the mutated cis-regulatory element is increased or decreased, depending on whether the transcription factor is a repressor or inducer, or whether the affinity of the transcription factor to the mutated cis-regulatory element is increased or decreased.If such a nucleobase exchange occurs, for example, in a coding region of the endogenous DNA sequence, this can lead to an amino acid exchange in the encoded protein, which can cause a change in the activity or stability of the protein compared to the wild-type protein. Another example of a genetic change is the deletion of nucleotides in the regulatory sequence and / or the endogenous DNA sequence, as well as the addition of nucleotides in the regulatory sequence and / or the endogenous DNA sequence. An example of the regulation of genes by insertion of nucleotides through transposon mutagenesis in maize is shown by Das & Martienssen (1995). An epigenetic change can occur, for example, through an altered methylation pattern of the DNA.

[0027] Those skilled in the art know how a mutation within the meaning of the invention can be achieved by the process of mutagenesis in step A) of the method for producing a plant suitable for use as a haploid inducer. Mutagenesis includes both conventional mutagenesis and site-specific mutagenesis, or genome editing. In conventional mutagenesis, the modification is not specifically induced at the DNA level. The plant cell or plant is exposed to mutagenic conditions such as TILLING by UV light irradiation or the use of chemical substances (Till et al., 2004). Another method of random mutagenesis is mutagenesis using a transposon. An extensive collection of mutants is freely available through the UniformMU project. The collection and method are described in McCarty et al. (2005).Site-directed mutagenesis enables the targeted introduction of modifications at predefined DNA sites. For this purpose, TALENS (WO 2010 / 079430, WO 2011 / 072246), meganucleases (Silva et al., 2011), homing endonucleases (Chevalier 2002), zinc finger nucleases (Lloyd et al., 2005), or a CRISPR / Cas system (Gaj et al., 2013) can be used.

[0028] The identification of a plant in step B) can be carried out, for example, with the help of molecular markers or probes. DNA probes are, for example, primers or primer pairs that can be used in a PCR reaction. For example, tilling mutants can be detected or identified by sequencing the target gene in a tilling population or other methods that detect mismatches in the DNA, such as melting point analyses or the use of mismatch-specific nucleases. The present invention also includes primers / primer pairs that can be used for this purpose, such as primers for phospholipase, phosphoglycerate mutase, methyltransferase, and lncRNA for phospholipase. Furthermore, mutants generated by means of transposons can be detected by using transposon-specific primers and target gene-specific primers in the PCR across the entire population and subsequent sequencing of PCR products.Such primers are also encompassed by the present invention. Changes in expression rate can be determined, for example, using RT-PCR in pollen, and changes in stability can be determined, for example, by examining ubiquitin binding sites and predicting changes in tertiary structure. Furthermore, recombinant expression of the wild-type proteins and the corresponding mutant proteins and subsequent biochemical activity tests are also suitable. The person skilled in the art is familiar with further means and methods that can be used to identify a plant in step B). The present invention also relates to molecular markers that detect the presence or absence of a mutation in the endogenous DNA sequence or in a regulatory sequence of the endogenous DNA sequence. Such markers are based, for example, on a SNP and are specific for the mutation (examples: KASPar or TaqMan markers).

[0029] The present invention further relates to a plant that can be produced or is produced using the above method, or to a part of this plant, wherein a part of a plant can be a fertilized or unfertilized seed, an embryo, a pollen, a tissue, an organ, or a plant cell, wherein the fertilized or unfertilized seed, the embryo, or the pollen is produced on the transgenic plant and in whose genome the at least one mutation is present. Likewise, the present invention also includes a progeny of the plant that has the at least one mutation and is suitable for use as a haploid inducer.

[0030] Furthermore, the present invention also relates to a method for isolating a nucleic acid which imparts the property of a haploid inducer in a plant or increases the induction performance of a haploid inducer, comprising the following steps: A) producing a plant according to the method described above or providing a plant which can be produced or has been produced using the method described above, and B) isolating a nucleic acid which comprises the endogenous DNA sequence with the at least one mutation from the genome of the plant from A). The isolation of the nucleic acid in step B) can be carried out by CTAB extraction or via DNA-binding columns, the detection of the mutation via sequencing or molecular markers, such as SNP-based KASPar or TaqMan markers, or in the case of insertion or deletion mutants via markers based on length polymorphisms.

[0031] The present invention also includes a nucleic acid obtained by the above-described method of isolation or obtainable by the above-described method of isolation, and a vector comprising the isolated nucleic acid.

[0032] In another aspect, the present invention also relates to a method for producing a transgenic plant suitable for use as a haploid inducer. The method may comprise the following steps: A) Providing the nucleic acid described above, which after transcription or after expression in a plant is suitable for imparting the property of a haploid inducer or for increasing the induction performance of a haploid inducer, or providing the isolated nucleic acid described above, which comprises the endogenous DNA sequence with the at least one mutation, or providing one of the vectors described above, B) Transforming, preferably stably transforming, plant cells by introducing the nucleic acid or the vector from A), C) Regenerating transgenic plants from the transformed plant cells from B), and D) Identifying a transgenic plant from C), in which by an altered expression pattern, preferably in the pollen of the identified plant or in a tissue of a pollen of the identified plant,the property of a haploid inducer is imparted or the induction performance of a haploid inducer is increased. The method for producing a transgenic plant suitable for use as a haploid inducer also includes the provision of two or more of the nucleic acids described above, optionally also different embodiments of the nucleic acid according to the invention and optionally in one or more vectors, and the transformation of plant cells by introducing the two or more nucleic acids. Alternatively or additionally, in addition to the nucleic acid according to the invention, one or more further nucleic acids known to be usable for generating a haploid inducer (e.g., manipulated cenh3 gene (Ravi & Chan, 2010)) can also be provided and transformed.

[0033] Preferably, the expression pattern is changed so that (I) the transcription or expression rate of the introduced induction-promoting nucleic acid is increased in the identified plant compared to a wild-type plant, which was regenerated, for example, from an isogenic, non-transformed plant cell. Detection of the transcription rate can be achieved, for example, by qRT-PCR. Altered protein stability can be determined, for example, by Western blot.

[0034] The present invention further relates to a transgenic plant that can be produced or is produced using this method, or to a part of this plant, where a part of a plant can be a fertilized or unfertilized seed, an embryo, pollen, a tissue, an organ, or a plant cell, where the fertilized or unfertilized seed, the embryo, or the pollen is produced on the transgenic plant and the nucleic acid according to the invention is integrated into its genome as a transgene or the vector. Likewise, the present invention also includes a progeny of the transgenic plant that has the introduced nucleic acid as a transgene and is suitable for use as a haploid inducer.

[0035] In another aspect, the present disclosure relates to a method for producing a haploid plant, comprising the following steps: A) crossing a non-transgenic or transgenic plant of the present invention suitable for use as a haploid inducer with a plant of the same genus, preferably the same species, B) selecting a fertilized haploid seed or embryo, and C) producing a haploid plant from the seed or embryo of B).

[0036] Preferably, the plant suitable for use as a haploid inducer is used as the pollen parent and crossed with a seed parent of the same genus, preferably the same species. The plant suitable for use as a haploid inducer can also be used as the seed parent and crossed with a pollen parent of the same genus, preferably the same species. Both crossing partners in step A), i.e., seed parent and pollen parent, can also be the same individual. In this case, the crossing step represents selfing.

[0037] Selecting the haploid fertilized seed or embryo can involve a step of detecting haploidy and separating the haploid fertilized seed or embryo from polyploid fertilized seeds or embryos. Detection of haploidy in a fertilized seed or embryo can be done phenotypically or genotypically, for example, by labeling the inducer with an embryo-specific dominant marker that is visible in all diploid offspring but not in the induced haploid offspring. Furthermore, the ploidy status can be determined via flow cytometry. Furthermore, a completely homozygous pattern of molecular markers indicates haploid plants. Separation can be automated, for example, based on data from the haploidy detection.

[0038] The present invention further relates to a haploid fertilized seed or embryo resulting from crossing in step A) of the method for producing a haploid plant, as well as to a haploid plant that can be produced or is produced by this method, or to a part of this plant, where a part of a plant can be a seed, an embryo, a tissue, an organ, or a plant cell. Likewise, the present invention also includes a progeny of the plant. Furthermore, the present invention also encompasses a double haploid (diploid) plant or a part thereof, where the double haploid (diploid) plant or the part thereof was produced by chromosome duplication of the haploid plant or the part thereof.

[0039] Double-stranded RNA for the preparation of the agent according to the invention can in vitroproduced by methods known to those skilled in the art. For example, the synthesis of the double-stranded RNA can be carried out synthetically, whereby the RNA in vitro is formed directly. The double-stranded RNA can also be synthesized from double-stranded DNA via the formation of an mRNA transcript, which then, for example, forms a hairpin structure. The agent can be used to trigger haploid induction in a plant. For example, the agent can be applied to the plant tissue by spraying it on or by other methods of external application familiar to the person skilled in the art, or by spraying it on or mixing it with other additives before or after flowering of the plants. Additives can be, for example, wetting agents, carrier substances, or RNA stabilizers such as liposomes.

[0040] The inventors have surprisingly discovered that genes or gene products that influence pollen tube growth, pollen energy metabolism, and / or centromere activity, preferably in a generative cell that develops into pollen, for example, are particularly suitable for converting a non-haploid inducer into a haploid inducer. Several gene / protein families of essential importance have been identified for this purpose. Their use in generating haploid inducers has so far neither been described nor suggested in the prior art.Since the formation of pollen and also the fertilization process (including the growth of the pollen tube) follows general principles in mono- and dicotyledonous plants, the technical teaching of the present invention gives the person skilled in the art the opportunity to develop haploid inducers even for cultivated plants for which no efficient system has been available so far. in vivo-Haploid induction or other cell culture-based methods for creating doubled haploid plants do not yet exist. For this purpose, the person skilled in the art can use the genetic information obtained through the present invention to routinely identify homologs, orthologs, or analogues of the described gene products and manipulate them as described here. However, the technical teaching of the present invention is also suitable for further improving existing inducers with regard to their efficiency (i.e., haploid induction rate), thus making them commercially viable. Furthermore, a person skilled in the art can combine this technical teaching with other known mechanisms of haploid induction, such as manipulation of the CENH3 protein (Ravi & Chan, 2010), and thus further increase efficiency.

[0041] Some of the terms used in this application are explained in more detail below: "B73" is a maize inbred line used as a model genotype in maize genetics and was used to create the first maize reference sequence.

[0042] "Conveying the property of a haploid inducer" or "conveying the property of a haploid inducer" or a comparable expression means that a plant is enabled, by using a nucleic acid according to the invention, to produce fertilized seeds or embryos having a single (haploid) set of chromosomes from a cross with a plant of the same genus, preferably of the same species, which does not have the property of a haploid inducer. The property of a haploid inducer, expressed as absolute haploid induction rate, means that at least 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9% or 1%, preferably at least 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5% or 5%, particularly preferably at least 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14% or 15%, or very particularly preferably at least 20%, 25%, 30%, 35%, 40%, 45% or 50% of the fertilized seeds or embryos have a haploid set of chromosomes.

[0043] "Increase in the expression rate" or "increased expression rate" or "activation of expression" or a comparable expression means an increase in the expression rate of a nucleotide sequence by more than 10%, 15%, 20%, 25%, or 30%, preferably by more than 40%, 50%, 60%, 70%, 80%, 90%, or 100%, particularly preferably by more than 150%, 200%, 250%, 300%, 500%, or 1000%, compared to the specified reference. Preferably, the increase in the expression rate leads to a change in the phenotype of a plant in which the expression rate is increased. An altered phenotype can be the imparting of the trait of a haploid inducer or the increase in the induction capacity of a haploid inducer.

[0044] "Increase in transcription rate" or "increased transcription rate" or a comparable expression means an increase in the transcription rate of a nucleotide sequence by more than 10%, 15%, 20%, 25%, or 30%, preferably by more than 40%, 50%, 60%, 70%, 80%, 90%, or 100%, particularly preferably by more than 150%, 200%, 250%, 300%, 500%, or 1000%, compared to the specified reference. Preferably, the increase in transcription rate leads to a change in the phenotype of a plant in which the transcription rate is increased. An altered phenotype can be the imparting of the trait of a haploid inducer or the increase in the induction efficiency of a haploid inducer.

[0045] A "functional fragment" of a nucleotide sequence means a section of a nucleotide sequence that has identical or comparable functionality to the entire nucleotide sequence from which the functional fragment originates. As such, the functional fragment can have a nucleotide sequence that is at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 92%, 94%, 96%, 97%, 98%, or 99% identical or homologous to the entire nucleotide sequence. Furthermore, a "functional fragment" of a nucleotide sequence can also mean a section of a nucleotide sequence that alters the functionality of the entire nucleotide sequence, for example, as a result of post-transcriptional or transcriptional gene silencing.As such, the functional fragment of a nucleotide sequence may comprise at least 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 or 25, preferably at least 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 120 or 140, particularly preferably at least 160, 180, 200, 250, 300, 350, 400, 450, 500, 600, 700, 800, 900 or 1000 consecutive nucleotides of the total nucleotide sequence.

[0046] A "functional part" of a protein refers to a section of a protein or a portion of the amino acid sequence that encodes the protein, where the section can perform identical or comparable functionality to the entire protein in a plant cell. A functional part of a protein has an amino acid sequence that is at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 92%, 94%, 96%, 97%, 98%, or 99% identical or, taking into account conservative and semi-conservative amino acid substitutions, similar to the protein from which the functional part originates. "Haploid inducer" also refers to an in vivo haploid inducer.

[0047] The term "heterologous" means that the introduced polynucleotide originates, for example, from a cell or organism with a different genetic background within the same species or a different species, or is homologous to the prokaryotic or eukaryotic host cell but is located in a different genetic environment, thus differing from any naturally occurring corresponding polynucleotide. A heterologous polynucleotide can be present in addition to a corresponding endogenous gene.

[0048] For the purposes of the invention, a "homolog" is understood to be a protein of the same phylogenetic origin, an "analog" is understood to be a protein that performs the same function but has a different phylogenetic origin, and an "ortholog" is understood to be a protein from another species that performs the same function.

[0049] "Hybridization" or "hybridization" refers to a process in which a single-stranded nucleic acid molecule binds to a largely complementary nucleic acid strand, i.e., undergoes base pairing. Standard hybridization procedures are described, for example, in Sambrook et al. (2001). Preferably, this means that at least 60%, more preferably at least 65%, 70%, 75%, 80%, or 85%, and particularly preferably 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% of the bases of the nucleic acid molecule base pair with the largely complementary nucleic acid strand. The possibility of such binding depends on the stringency of the hybridization conditions. The term "stringency" refers to the hybridization conditions. High stringency occurs when base pairing is difficult, low stringency occurs when base pairing is easier.The stringency of the hybridization conditions depends, for example, on the salt concentration or ionic strength and the temperature. In general, stringency can be increased by increasing the temperature and / or decreasing the salt content. "Stringent hybridization conditions" are those conditions under which hybridization occurs predominantly only between homologous nucleic acid molecules. The term "hybridization conditions" refers not only to the conditions prevailing during the actual annealing of the nucleic acids, but also to the conditions prevailing during the subsequent washing steps. Stringent hybridization conditions are, for example, conditions under which predominantly only those nucleic acid molecules hybridize that exhibit at least 70%, preferably at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% sequence identity.Stringent hybridization conditions include, for example, hybridization in 4× SSC at 65°C followed by multiple washes in 0.1× SSC at 65°C for a total of approximately 1 hour. The term "stringent hybridization conditions" used here can also mean hybridization at 68°C in 0.25 M sodium phosphate, pH 7.2, 7% SDS, 1 mM EDTA, and 1% BSA for 16 hours, followed by two washes with 2× SSC and 0.1% SDS at 68°C. Hybridization under stringent conditions is preferred.

[0050] "Increasing the induction efficiency of a haploid inducer" or "increasing the induction efficiency of a haploid inducer" means increasing the haploid induction rate of a plant that has the trait of a haploid inducer. Thus, the number of fertilized seeds which have a haploid set of chromosomes and have resulted from a cross of the haploid inducer with a plant of the same genus, preferably the same species, which does not have the property of a haploid inducer, can be at least 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9% or 1%, preferably at least 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5% or 5%, and particularly preferably at least 6%, 7%, 8%, 9%, 10%, 15%, 20%, 30% or 50% higher than the number of haploid fertilized seeds which is achieved without the use of the nucleic acid in the sense of the present invention, iethe haploid induction rate can be increased by at least 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9% or 1%, preferably at least 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5% or 5%, and particularly preferably at least 6%, 7%, 8%, 9%, 10%, 15%, 20%, 30% or 50% relative to the previously achieved haploid induction rate.

[0051] "Operatively linked" means linked in a common nucleic acid molecule in such a way that the linked elements are positioned and oriented relative to each other in such a way that transcription of the nucleic acid molecule can occur. DNA that is operatively linked to a promoter is under the transcriptional control of that promoter.

[0052] Plant "organs" include, for example, leaves, stems, roots, vegetative buds, meristems, embryos, anthers, ovules, or fruits. Plant "parts" include a combination of several organs, e.g., a flower or a seed, or a part of an organ, e.g., a cross-section of a stem. Plant "tissue" includes, for example, callus tissue, storage tissue, meristematic tissue, leaf tissue, shoot tissue, root tissue, plant tumor tissue, or reproductive tissue. Plant "cells" include, for example, isolated cells with a cell wall or aggregates thereof or protoplasts.

[0053] A "plant" within the meaning of the invention can, unless otherwise stated, be any species from the dicotyledonous, monocotyledonous, and gymnospermous plants. These include, for example, Barley , Sorghum bicolor , Rye cereal , triticale, Sugarcane , Corn , Setaria italic , White rice , Small rice , Australasian rice, Tall rice , Summer wheat , Durum wheat , Barley bulbous , Brachypodium distachyon , Sea barley , Aegilops tauschii , Beetroot , Sunflower , Daucus glochidiatus , Little duck , Muricated duckweed , Carrot , Eucalyptus grandiflora , Erythranthes guttata , Golden genlis , Gossypium sp. , Musa sp. , Avena sp., Nicotiana sylvestris , Nicotiana tabacum , Nicotiana tomentosiformis , Solanum tomato , Solanum tuberosum , Coffee cane toad , Wine grapevine , Cucumber , Notable mulberry , Arabidopsis thaliana , Arabidopsis lyrata , Arabidopsis sand , Himalayan Cross , Crucihimalaya wallichii , Cardamine flexuosa , Virginal Lepidium , Shepherd's purse-cap , Olmarabidopsis pumila, Arabis hirsuta , Brassica napus , Brassica oleracea , Turnip cabbage , Brassica juncea , Black cabbage , Radish , Yellow bladderworm , Citrus sinensis , Jatropha curcas , Glycine max and Populus trichocarpa. A plant according to the invention is preferably a plant of the genus Zea, in particular of the species Zea mays, or sorghum.

[0054] "Reduction in the expression rate" or "reduction in the expression rate" or "suppression of expression" "reduced expression rate" or a comparable expression means a reduction in the expression rate of a nucleotide sequence by more than 10%, 15%, 20%, 25%, or 30%, preferably by more than 40%, 45%, 50%, 55%, 60%, or 65%, particularly preferably by more than 70%, 75%, 80%, 85%, 90%, 92%, 94%, 96%, or 98%, compared to the specified reference. However, it can also mean that the expression rate of a nucleotide sequence is reduced by 100%. Preferably, the reduction in the expression rate leads to a change in the phenotype of a plant in which the expression rate is reduced. An altered phenotype can be the transfer of the trait of a haploid inducer or the increase of the induction power of a haploid inducer.

[0055] "Reduction in the transcription rate" or "reduced transcription rate" or a comparable expression means a reduction in the transcription rate of a nucleotide sequence by more than 10%, 15%, 20%, 25%, or 30%, preferably by more than 40%, 45%, 50%, 55%, 60%, or 65%, particularly preferably by more than 70%, 75%, 80%, 85%, 90%, 92%, 94%, 96%, or 98%, compared to the specified reference. However, it can also mean that the expression rate of a nucleotide sequence is reduced by 100%. Preferably, the reduction in the transcription rate leads to a change in the phenotype of a plant in which the transcription rate is reduced. An altered phenotype can be the transfer of the trait of a haploid inducer or the increase of the induction power of a haploid inducer.

[0056] In the context of the present invention, the term "regulatory sequence" refers to a nucleotide sequence that influences specificity and / or expression levels, for example, by mediating a particular tissue specificity. Such a regulatory sequence can be located upstream of the transcription initiation point of a minimal promoter, but also downstream of it, such as in a transcribed but untranslated leader sequence or within an intron.

[0057] "Suitable for use as a haploid inducer" means that a plant is capable of producing fertilized seeds having a single (haploid) set of chromosomes from a cross with a plant of the same genus, preferably the same species, which does not have the property of a haploid inducer. The use as a haploid inducer, expressed as absolute haploid induction rate, means that at least 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9% or 1%, preferably at least 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5% or 5%, particularly preferably at least 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14% or 15%, or very particularly preferably at least 20%, 25%, 30%, 35%, 40%, 45% or 50% of the fertilized seeds have a haploid set of chromosomes.

[0058] Embodiments and embodiments of the present invention are described by way of example with reference to the attached figures and sequences: Figure 1 : Genomic arrangement of the identified genes compared to B73 (AGPv02): SNAREv 1 (GRMZM2G179789): increased expression in RWS pollen; SNAREv 2 (GRMZM2G412426): increased expression in RWS pollen; ITP (Inositol-1,4,5-triphosphate-5-phosphatase) (GRMZM2G106834): reduced expression in RWS pollen; PL (Patatin Phospholipase) (GRMZM2G471240): polymorphisms in coding and regulatory sequence; PGM (Phosphoglycerate Mutase) (GRMZM2G062320): deleted in RWS; lncRNA: homolog to PL: deleted in RWS; AC213048: anchor gene for sequence comparison; MT (RNA methyltransferase) (GRMZM2G347808): Polymorphisms in the regulatory region. The GRMZM names refer to the annotation in AGPv02. Figure 2 : RT-PCR on mature pollen in inducer RWS and three non-inducer controls (NI1, NI2, NI3) on the genes SNAREv 1, RNA methyltransferase and patatin phospholipase.

[0059] QTL analysis and identification of candidate genes: In the maize haploid inducer RWS, which is derived from the inducer Stock6 (literature), a major QTL on chromosome 1 (bin 1.04) was identified and fine-mapped. This QTL appears to be similar to a QTL already described in the state of the art (literature). Based on this work, the QTL in RWS was to be verified and molecularly analyzed to identify the underlying genes and functionally validate them. A QTL mapping population consisting of RWS x Control1 (maternal inducer x non-inducer) was tested for induction performance. This demonstrated that the known QTL is likely also present in the inducer RWS. Furthermore, a strong allelic bias favoring the non-RWS (Control 1) allele was also detected.

[0060] To characterize the locus molecularly, various sequencing approaches were used at the DNA and RNA levels. Due to structural differences between inducers and the reference genome B73, the conventional reference-based sequencing approaches were only marginally successful. Extensive and complex bioinformatics analyses revealed that structural differences had to be verified using other technologies.

[0061] Using a sequence capture approach, approximately three megabases around the identified QTL were sequenced in three Stock6-derived inducers, including RWS, and five non-inducer controls and analyzed for inducer-specific polymorphisms such as presence-absence variations, SNPs, and InDels. Initially, 16 candidate genes were identified, of which three genes were confirmed by re-sequencing and analysis of expression data: a gene encoding an anther-specific patatin phospholipase A2, which has an RWS inducer-specific haplotype, a phosphoglycerate mutase gene, which is absent in the inducer RWS, and an RNA methyltransferase gene, which has a mutation in a regulatory sequence.

[0062] Furthermore, BAC libraries were developed for RWS, EMK (another Stock6-derived inducer), and Control 1 and screened with probes distributed across the identified QTL. For a target region of approximately 150 kb, which was suggested by Dong et al. (2013) to be potentially inducer-relevant in the inducer UH400, BACs from RWS, Control 1, and EMK were fished and sequenced. The BAC sequences were annotated and aligned with extensive transcriptome data generated for RWS, Control 1, EMK, and B73.

[0063] The results confirmed the deletion in the inducer. Accordingly, the maternal inducers examined lack a region of approximately 100 kb between 68.26 and 68.36 MB (AGP version 2 of the B73 reference sequence) on chromosome 1. Furthermore, outside the target region, the inducers exhibit an inversion in a gene-like region and a large repetitive sequence section that is not comparable with the reference genome of B73 and with Control1.

[0064] The previously identified phospholipase is still present in the inducers despite the deletion, but displays the haplotype already mentioned, which differs significantly from the controls, as well as significant genetic alterations in the promoter region. As a result of the deletion, the phosphoglycerate mutase identified above is no longer present in the inducers.

[0065] Furthermore, a non-coding RNA (lncRNA) was identified in the 100 kb deletion. Like the phospholipase, it is expressed in a pollen-specific manner and also shows 82% homology to the identified phospholipase. The sequence is complementary, meaning the lncRNA forms a hairpin structure. The very high expression rate, the significant homology to the phospholipase, and the low SNP density determined by Sanger sequencing indicate a regulatory function of this lncRNA for the phospholipase. Theoretically, an 88-amino acid truncated version of the phospholipase protein could also be translated from this transcript.

[0066] To measure differences in the expression levels of the identified genes from the region in addition to polymorphisms at the DNA level, RT-PCR and RNASeq experiments were conducted. In addition to RWP (a subline of RWS) as the inducer, three genetically very different control lines were used. Pollen, anthers without pollen, and embryos 6–7 days post-pollination from selfings or crosses were harvested from these plants. Phospholipase showed slightly elevated expression in the pollen of RWP. Methyltransferase showed weak expression in the pollen of RWP and no expression in the pollen of the controls. The lncRNA is pollen-specifically expressed and, as expected, is also absent in RWP.

[0067] Additionally, RNASeq was applied to pollen from the same material to further verify the above results. Unexpectedly, new candidate genes were identified outside, but close to, the above-mentioned fine-mapped region, which could not be detected previously, likely due to technical limitations of the SeqCapture approach. Approximately 400 kb upstream of the identified phospholipase from the fine-mapped region lies a gene complex that is significantly differently expressed (at least a factor of 2) in pollen from RWP compared to controls. This gene complex contains three genes: two genes annotated as SNAREv genes, which show high homology to each other and are overexpressed in RWP, and one gene annotated as inositol-1,4,5-trisphosphate-5-phosphatase, whose expression is reduced in RWP.Cloned transcripts of these genes sometimes differ significantly from the public annotation, meaning they can encode proteins with different functions or even function as lncRNAs. Sequence capture data from this region already show significant structural differences between inducers, controls, and the reference genome. The inositol 1,4,5-trisphosphate 5-phosphatase gene, as annotated in B73, could not be fully amplified in the inducers. The isolation of a cDNA from one of the SNARE genes (GRMZM2G179789) also indicates complex structural changes in the inducers, as part of the cDNA corresponds to the plus strand and part to the minus strand of the reference.

[0068] Furthermore, this gene complex also contains a previously unknown gene encoding a long non-coding RNA. This gene shares a common transcription start site with the identified inositol 1,4,5-trisphosphate 5-phosphatase, but is activated by the opposite strand. Gene functionalities

[0069] Thus, a total of six genes were identified which are important for the in life Haploid induction or the in life haploid induction performance in maize.

[0070] Among them are four genes that are particularly important for pollen tube growth: The two SNAREv genes encode proteins that are known to be involved in vesicle transport (literature). Arabidopsis thalianaSNAREv proteins have already been detected at the tip of the pollen tube, where they are involved in the transport of phospholipids and pectins (literature). The overexpression of SNAREv proteins observed in the maize inducers studied would lead to increased pollen tube growth.

[0071] That phospholipase A2 also significantly influences pollen tube growth was demonstrated in the model plant Nicotiana tabacum The inhibition of phospholipase A2 thus leads to a suppression of pollen tube growth (Kim et al., 2011). In the maize inducers studied, the absence of the identified lncRNA with significant homology to phospholipase can lead to a reduction in the expression or translation rate of the phospholipase gene, which would accelerate the growth rate of the pollen tube.

[0072] In a knock-out mutant of inositol polyphosphate 5-phosphatase in Arabidopsis thalianaIt was shown that the pollen tube grows uninhibitedly. In the maize inducers studied, the reduced expression level of inositol 1,4,5-trisphosphate 5-phosphatase can thus also lead to accelerated pollen tube growth. The identified lncRNA associated with inositol 1,4,5-trisphosphate 5-phosphatase could have a regulatory effect on the expression rate.

[0073] Thus, the maize inducers studied exhibit altered regulation / expression rates of the four genes compared to non-inducers. This disruption should lead to significantly faster pollen tube growth, resulting in a decoupling of the transport of generative cells in the pollen tube from its growth. This can lead to incomplete or defective fertilization with subsequent chromosome elimination.

[0074] Active centromeres are known to play a key role in chromosome distribution and are characterized and modified via chromatin modifications at the DNA or histone level, as well as by transcription, RNA interactions, and RNA binding. Alterations in the regulation of the methyltransferase gene can affect the activity of inducer centromeres during early embryogenesis, ultimately leading to the elimination of the inducer genome at the early stage of grain development.

[0075] In the inducers studied, it was shown that the phosphoglycerate mutase gene is no longer present. The absence of this gene can impair pollen energy metabolism and thus impact fertilization.

[0076] Any gene alone or any combination of genes can be responsible for the effect of haploid induction. Creation of new in life Haploid inducers

[0077] To develop a new inducer in other crops or maize non-inducer genotypes, or to increase the induction efficiency of an inducer genotype, the following procedure must be followed: Identification of the corresponding genes in other crops or maize non-inducer genotypes: The pollen-specific patatin phospholipases are highly conserved in monocotyledonous plants such as maize, rice, wheat, rye, or barley, and therefore their homologs are easy to identify. Regulatory lncRNAs, on the other hand, are absent in most monocotyledonous plants. However, if they are present, they can also be identified based on significant homologies, as was also observed in the maize inducers studied. In dicotyledonous plants, other phospholipase types perform the corresponding functions in pollen tube growth.To identify these, RNA libraries of pollen or pollen tubes must be created and screened for the specific phospholipase of the present invention.

[0078] The SNAREv genes and the methyltransferase gene do not have to be pollen-specific. For example, one of the identified SNAREv genes (SNAREv 1) is not expressed in a pollen-specific manner in maize. SNAREv 1 is not expressed at all in wild-type pollen. In annotated genomes, homologous genes can be identified using BLASTP and the functional domain of a SNAREv protein. In unannotated genomes, RNASeq data would have to be annotated and selected for SNARE genes.

[0079] Homologous inositol 1,4,5-trisphosphate 5-phosphatases and phosphoglycerate mutases must be expressed in pollen to be used as candidate genes. Identification can be performed as above using BLASTP followed by RT-PCR in pollen or by annotation of RNASeq data on pollen.

[0080] Manipulation of candidate genes: Potential inducers or enhanced induction performance can be achieved through transgenic expression of the above-identified phospholipases and / or SNAREs and / or methyltransferases and / or phosphoglycerate mutases and / or lncRNAs. For this purpose, the corresponding genes, including their promoters, would be cloned from the inducer line RWP. These genes would be cloned into a suitable transformation vector and transformed into the desired plant.

[0081] The activity of inositol 1,4,5-trisphosphate 5-phosphatase expressed in pollen can be reduced additionally or exclusively, for example, via RNAi. For this purpose, hairpin constructs can be generated, including a suitable promoter and terminator that allow transcription of the hairpin construct before or at the time of pollen formation. These hairpin constructs would then be cloned into a suitable transformation vector and transformed into the desired plant.

[0082] Alternatively or additionally, TILLING, transposon mutagenesis, or other mutagenesis techniques or genome editing can be used to generate plants with mutations, for example, in the identified genes that stabilize phospholipase, SNAREs, and / or methyltransferase, enhance expression, or increase activity. Structural analyses of the secondary and tertiary structure of the mutated proteins can be helpful for this purpose, as they indicate, for example, denser structures and thus fewer targets for proteases. Furthermore, the regions of the proteins that play a role in ubiquitin interactions can be examined. Mutants in the active site of the gene can be tested directly for their activity. To manipulate the activity of inositol 1,4,5-triphosphate 5-phosphatase or phosphoglycerate mutase, one must search for knockout mutants or mutants that reduce gene activity.

[0083] Furthermore, a Stock6-derived inducer can be improved. This is possible using the transgenic approach described above, as well as by introducing mutations in the identified candidate genes. In addition, it would be possible to manipulate additional copies of the genes in the genome, provided they are expressed in pollen, using transgenic or non-transgenic approaches.

[0084] Testing the induction power: To test the induction power of a potential inductor, there are the following options, for example: 1. Pollination of a line with a visual recessive marker (for maize, e.g., glossy (Bordes et al., 1997) or liguless (Sylvester et al., 1990)). Progeny expressing this trait are tested for haploidy using flow cytometry. 2. Pollination of a line that differs genetically from the inducer, if possible by several markers. Use these markers to identify homozygous plants. These plants are tested for haploidy using flow cytometry. References

[0085] Barret, P., Brinkmann, M., & Beckert, M. (2008). A major locus expressed in the male gametophyte with incomplete penetrance is responsible for in situ gynogenesis in maize. Theoretical and Applied Genetics, 117(4), 581-594. Bordes, J., de Vaulx, R. D., Lapierre, A., & Pollacsek, M. (1997). Haplodiploidization of maize (Zea mays L) through induced gynogenesis assisted by glossy markers and its use in breeding. Agronomie, 17(5), 291-297. Chen, L., Tu, Z., Hussain, J., Cong, L., Yan, Y., Jin, L., ... & He, G. (2010). Isolation and heterologous transformation analysis of a pollen-specific promoter from wheat (Triticum aestivum L.). Molecular biology reports, 37(2), 737-744. Chevalier, B. S., Kortemme, T., Chadsey, M. S., Baker, D., Monnat Jr, R. J., & Stoddard, B. L. (2002). Design, activity, and structure of a highly specific artificial endonuclease. Molecular cell, 10(4), 895-905. Coe, E. H. (1959). A line of maize with high haploid frequency. American Naturalist, 381-382. Das, L., & Martienssen, R. (1995). Site-selected transposon mutagenesis at the hcf106 locus in maize. The Plant Cell Online, 7(3), 287-294. Deimling, S., Röber, F. K., Geiger, H. H. (1997). Methodik und Genetik der in-vivo-Haploideninduktion bei Mais. Vortr. Pflanzenzüchtung 38: 203-224. Depicker, A., Stachel, S., Dhaese, P., Zambryski, P., & Goodman, H. M. (1981). Nopaline synthase: transcript mapping and DNA sequence. Journal of molecular and applied genetics, 1(6), 561-573. Dong, X., Xu, X., Li, L., Liu, C., Tian, X., Li, W., & Chen, S. (2014). Marker-assisted selection and evaluation of high oil in vivo haploid inducers in maize. Molecular Breeding, 1-12. Dong, X., Xu, X., Miao, J., Li, L., Zhang, D., Mi, X., ... & Chen, S. (2013). Fine mapping of qhir1 influencing in vivo haploid induction in maize. Theoretical and Applied Genetics, 126(7), 1713-1720. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998).Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. nature, 391(6669), 806-811. Gaj, T., Gersbach, C. A., & Barbas III, C. F. (2013). ZFN, TALEN, and CRISPR / Cas-based methods for genome engineering. Trends in biotechnology, 31(7), 397-405. Gurr, S. J., & Rushton, P. J. (2005). Engineering plants with increased disease resistance: what are we going to express?. TRENDS in Biotechnology, 23(6), 275-282. Kato, N., He, H., & Steger, A. P. (2010). A systems model of vesicle trafficking in Arabidopsis pollen tubes. Plant physiology, 152(2), 590-601. Kim, H. J., Ok, S. H., Bahn, S. C., Jang, J., Oh, S. A., Park, S. K., ... & Shin, J. S. (2011). Endoplasmic reticulum-and golgi-localized phospholipase A2 plays critical roles in Arabidopsis pollen development and germination. The Plant Cell Online, 23(1), 94-110. Lloyd, A., Plaisier, C. L., Carroll, D., & Drews, G. N. (2005). Targeted mutagenesis using zincfinger nucleases in Arabidopsis.Proceedings of the National Academy of Sciences of the United States of America, 102(6), 2232-2237. McCarty, D. R., Mark Settles, A., Suzuki, M., Tan, B. C., Latshaw, S., Porch, T., ... & Curtis Hannah, L. (2005). Steady-state transposon mutagenesis in inbred maize. The Plant Journal, 44(1), 52-61. Odell, J. T., Nagy, F., & Chua, N. H. (1985). Identification of DNA sequences required for activity of the cauliflower mosaic virus 35S promoter. Prigge, V., Xu, X., Li, L., Babu, R., Chen, S., Atlin, G. N., & Melchinger, A. E. (2012). New insights into the genetics of in vivo induction of maternal haploids, the backbone of doubled haploid technology in maize. Genetics, 190(2), 781-793. Ravi, M., & Chan, S. W. (2010). Haploid plants produced by centromere-mediated genome elimination. Nature, 464(7288), 615-618. Röber, F. K., Gordillo, G. A., & Geiger, H. H. (2005). In vivo haploid induction in maizeperformance of new inducers and significance of doubled haploid lines in hybrid breeding.Maydica, 50(3 / 4), 275. Sambrook, J., Russell, D. W., & Russell, D. W. (2001). Molecular cloning: a laboratory manual (3-volume set) (Vol. 999). Cold Spring Harbor, New York:: Cold spring harbor laboratory press. Shibuya, K., Fukushima, S., & Takatsuji, H. (2009). RNA-directed DNA methylation induces transcriptional activation in plants. Proceedings of the National Academy of Sciences, 106(5), 1660-1665. Silva, G., Poirot, L., Galetto, R., Smith, J., Montoya, G., & Duchateau, P. (2011). Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy. Current gene therapy, 11(1), 11. Sylvester, A. W., Cande, W. Z., & Freeling, M. (1990). Division and differentiation during normal and liguleless-1 maize leaf development. Development, 110(3), 985-1000. Till, B. J., Reynolds, S. H., Weil, C., Springer, N., Burtner, C., Young, K., ... & Henikoff, S. (2004). Discovery of induced point mutations in maize genes by TILLING. BMC Plant Biology, 4(1), 12.Twell, D., Yamaguchi, J., Wing, R. A., Ushiba, J., & McCormick, S. (1991). Promoter analysis of genes that are coordinately expressed during pollen development reveals pollen-specific enhancer sequences and shared regulatory elements. Genes & development, 5(3), 496-507. Venter, M. (2007). Synthetic promoters: genetic control through cis engineering. Trends in plant science, 12(3), 118-124. Wang, Y., Chu, Y. J., & Xue, H. W. (2012). Inositol polyphosphate 5-phosphatase-controlled Ins (1, 4, 5) P3 / Ca2+ is crucial for maintaining pollen dormancy and regulating early germination of pollen. Development, 139(12), 2221-2233. Zhao, Y., Zhao, Q., Ao, G., & Yu, J. (2006). Characterization and functional analysis of a pollen-specific gene st901 in Solanum tuberosum. Planta, 224(2), 405-412. WO / 2010 / 079430 (Bonas et al.) Modular DNA-binding domains and methods of use WO / 2011 / 072246 (Regents of the University of Minnesota) TAL effector-mediated DNA modification.WO 2012 / 030893 (Monsanto Technology LLC) Molecular markers associated with haploid induction in . Zea mays.

Claims

1. A nucleic acid which, after transcription or after expression in a plant, is capable of mediating the property of a haploid inducer or of increasing the induction capacity of a haploid inducer, characterized in that the nucleic acid comprises a nucleotide sequence which (i) has the sequence according to one of SEQ ID NO: 9, 49 or 52, or (ii) has the coding sequence according to one of SEQ ID NO: 11, 50 or 53 or a functional fragment of SEQ ID NO: 11 which is a section of SEQ ID NO: 11 and comprises at least 350 consecutive nucleotides of SEQ ID NO: 11, or (iii) is complementary to a sequence of SEQ ID NO: 9, or (iv) is at least 90% identical to a sequence of SEQ ID NO: 9, or (v) encodes a protein having the amino acid sequence selected from SEQ ID NO: 23, 51 or 54.

2. A vector comprising the nucleic acid according to claim 1.

3. A host cell comprising the nucleic acid according to claim 1 or the vector according to claim 2.

4. A transgenic plant cell comprising the nucleic acid according to claim 1 as transgene or the vector according to claim 2.

5. A transgenic plant or a seed thereof comprising a plant cell according to claim 4.

6. A method of producing a plant suitable for use as a haploid inducer comprising the following steps: A) Mutagenizing plant cells and subsequently regenerating plants from the mutagenized plant cells or mutagenizing plants, and B) Identifying a plant of A) which in an endogenous DNA sequence which is identical to a nucleic acid comprising a nucleotide sequence which (i) has the sequence according to SEQ ID NO: 8, or (ii) has the coding sequence according to SEQ ID NO: 10, or (iii) is complementary to a sequence of (i) or (ii), or (iv) is at least 80% identical to a sequence of (i) or (ii), or (v) encodes for a protein having the amino acid sequence selected from SEQ ID NO: 21 or 22, a functional part of SEQ ID NO: 21 or 22 which has an identical amino acid sequence over a length of at least 60%, or to the nucleic acid according to claim 1, or in a regulatory sequence of the endogenous DNA sequence has at least one mutation which causes a change in the transcription or expression rate of the endogenous DNA sequence in the identified plant in comparison to a non-mutagenized wild type plant or a change in the activity or stability of a protein or polypeptide, encoded by the endogenous DNA sequence, in the identified plant in comparison to a non-mutagenized wild type plant, wherein the at least one mutation causes the property of a haploid inducer to be imparted in the identified plant or the induction capacity of a haploid inducer to be increased.

7. A plant or a seed of the plant produced by the method according to claim 6, wherein the at least one mutation is a change in the coding sequence of SEQ ID NO: 8 or 9 which causes an amino acid substitution between amino acid positions 74 and 78 of SEQ ID NO: 21, 22 or 23.

8. The plant or the seed of the plant according to claim 7 or produced by the method according to claim 6, comprising the sequence according to one of SEQ ID NO: 49 or 52, or the coding sequence according to one of SEQ ID NO: 50 or 53.

9. A method for isolating a nucleic acid which imparts the property of a haploid inducer or increases the inducing capacity of a haploid inducer in a plant, comprising the following steps: A) Preparing a plant according to the method of claim 6 or providing a plant according to claim 7 or 8, B) Isolating a nucleic acid comprising the endogenous DNA sequence with the at least one mutation from the genome of the plant of A).

10. A method of producing a transgenic plant suitable for use as a haploid inducer comprising the following steps: A) Providing the nucleic acid according to claim 1 or the vector according to claim 2, B) Transforming plant cells by inserting the nucleic acid or the vector of A), C) Regenerating transgenic plants from the transformed plant cells of B), and D) Identifying a transgenic plant from C) in which the property of a haploid inducer is imparted by an altered expression pattern or the induction capacity of a haploid inducer is increased.

11. A use of the nucleic acid according to claim 1 or the vector according to claim 2 in a plant for imparting the property of a haploid inducer or for increasing the induction capacity of a haploid inducer or for producing a plant or a transgenic plant which is suitable for use as a haploid inducer.

12. A plant comprising a nucleic acid which (i) has the sequence according to one of SEQ ID NO: 49 or 52, or (ii) has the coding sequence according to one of SEQ ID NO: 50 or 53, or (iii) encodes a protein having the amino acid sequence selected from SEQ ID NO: 51 or 54.

13. Plant comprising a DNA having the sequence according to SEQ ID NO: 11.